Hyperphosphatemia and MBD: Understanding the Link and Effective Management

This presentation describes the characteristics of phosphate binders and their modes of action, the clinical effects of phosphate binders, how vitamin D and calcimimetics can be used in the treatment of secondary hyperparathyroidism and discusses the barriers to CKD-MBD management.

All webinars are eligible for continuing education (CE) contact hours. Registration is required to receive CE contact hours. Please click the Register button above (if applicable, this button only appears for an upcoming course) to create an account (if necessary), and register for this session. Following the webinar, you will receive an email with a post-webinar CE survey. The survey must be completed in order to get a CE contact hour certificate. Fresenius Medical Care North America Renal is approved by the California Board of Registered Nursing (Provider # CEP 7570) to provide continuing education contact hours. Eligible participant(s) can receive credit; however, it is their responsibility to check with their licensing board to determine if they accept continuing education contact hours from the California Board of Registered Nursing.